International Business News - VRX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Valeant Pharmaceuticals International said Friday it bought Australia-based DermaTech Pty Ltd. for 19 million Australian dollars ($12.2 million) in a move to expand its dermatology business. http://www.ibtimes.com/articles/20081114/valeant-pharmaceuticals-buys-dermatech.htm Fri, 14 Nov 2008 09:52:32 EST Valeant Pharmaceuticals International said Thursday it turned a profit in the third quarter after selling its businesses in western and eastern Europe, Africa and the Middle East. http://www.ibtimes.com/articles/20081106/valeant-turns-3q-profit-after-paring-business.htm Thu, 06 Nov 2008 12:03:52 EST Valeant Pharmaceuticals International said Friday that British drugmaker GlaxoSmithKline PLC will market Valeant's epilepsy drug Diastat AcuDial in the U.S. http://www.ibtimes.com/articles/20081024/glaxosmithkline-to-market-valeant-seizure-drug.htm Fri, 24 Oct 2008 09:16:56 EDT Valeant Pharmaceuticals International said Friday it received an upfront payment of $125 million for a collaboration with GlaxoSmithKline to develop a new epilepsy treatment. http://www.ibtimes.com/articles/20081017/valeant-gets-125-million-payment-from-glaxo.htm Fri, 17 Oct 2008 08:45:23 EDT Valeant Pharmaceuticals Inc. said Wednesday it will buy privately held Coria Laboratories Ltd. for $95 million in a move to expand its dermatology business. http://www.ibtimes.com/articles/20080917/valeant-buying-coria-for-95-million.htm Wed, 17 Sep 2008 09:39:01 EDT Drug maker Valeant Pharmaceuticals Inc. said Friday it completed the sale of its Eastern and Western European businesses to Meda AB of Sweden. Valeant agreed to sell most of its operations in Europe on Aug. 4, for $425 million in cash. The company did not sell its Central European business, which consist of operations in Poland, Hungary, Slovakia and the Czech Republic. http://www.ibtimes.com/articles/20080912/valeant-closes-425-million-unit-sale-to-meda-ab.htm Fri, 12 Sep 2008 07:24:14 EDT Valeant Pharmaceuticals International said Thursday it will collaborate with GlaxoSmithKline PLC to develop and market epilepsy drug candidates in a deal that could bring Valeant payments of up to $825 million, along with sales royalties. http://www.ibtimes.com/articles/20080828/valeant-and-glaxo-enter-epilepsy-drug-pact.htm Thu, 28 Aug 2008 11:26:36 EDT Among the earnings stories for Monday, Aug. 11, from AP Financial News: ALISO VIEJO, Calif. (AP)--Valeant Pharmaceuticals International on Monday reported a second-quarter loss as the company continued to pare its operations by eliminating businesses overseas. http://www.ibtimes.com/articles/20080811/earnings-roundup-valeant-pharma-liberty-media.htm Mon, 11 Aug 2008 14:27:54 EDT Valeant Pharmaceuticals International on Monday reported a second-quarter loss as the company continued to pare its operations by eliminating businesses overseas. http://www.ibtimes.com/articles/20080811/valeant-posts-2nd-quarter-loss-as-sales-slip.htm Mon, 11 Aug 2008 10:56:44 EDT Valeant Pharmaceuticals International and Meda AB said Thursday they will collaborate to develop and market current and future products in Australia, Canada and Mexico, starting with treatments for insomnia and pain. http://www.ibtimes.com/articles/20080807/valeant-meda-announce-joint-pharma-ventures.htm Thu, 07 Aug 2008 12:14:44 EDT The general counsel of specialty pharmaceutical company Valeant Pharmaceuticals International bought 2,054 shares of common stock, according to a Securities and Exchange Commission filing Tuesday. http://www.ibtimes.com/articles/20080709/valeant-pharmaceuticals-general-counsel-buys-stock.htm Wed, 09 Jul 2008 15:22:37 EDT The chief executive of specialty pharmaceutical company Valeant Pharmaceuticals International bought 51,440 shares of stock, according to a Securities and Exchange Commission filing Monday. http://www.ibtimes.com/articles/20080708/valeant-pharmaceuticals-ceo-buys-shares.htm Tue, 08 Jul 2008 15:14:27 EDT The executive vice president and chief administrative officer of Valeant Pharmaceuticals International, a specialty pharmaceutical company, bought 2,049 shares of common stock, according to a Securities and Exchange Commission filing Friday. http://www.ibtimes.com/articles/20080630/valeant-pharmaceuticals-evp-buys-shares.htm Mon, 30 Jun 2008 16:01:02 EDT Valeant Pharmaceuticals International said Friday it will redeem all the $300 million of its 7 percent senior notes due 2011. Valeant, whose pharmaceutical products focus on neurology, dermatology and infectious disease, plans to redeem the notes on July 21. http://www.ibtimes.com/articles/20080620/valeant-pharmaceuticals-to-redeem-7-percent-notes.htm Fri, 20 Jun 2008 17:52:58 EDT The chairman and chief executive of Valeant Pharmaceuticals International, a specialty pharmaceutical company, bought 49,900 shares of common stock, according to a Securities and Exchange Commission filing Monday. http://www.ibtimes.com/articles/20080617/valeant-pharmaceuticals-ceo-pearson-buys-shares.htm Tue, 17 Jun 2008 16:59:40 EDT Valeant Pharmaceuticals International said Tuesday its board approved a $100 million expansion of its share repurchase program. The additional authorization brings the total repurchase amount to $300 million over a 24-month period begun in June 2007. http://www.ibtimes.com/articles/20080617/valeant-adds-100-million-to-buyback-plans.htm Tue, 17 Jun 2008 08:50:17 EDT Valeant Pharmaceuticals International said Thursday that its mid-stage hepatitis C candidate taribavirin could replace a drug used in a common treatment regimen. http://www.ibtimes.com/articles/20080612/valeant-says-hepatitis-c-drug-causes-less-anemia.htm Thu, 12 Jun 2008 13:16:35 EDT Valeant Pharmaceuticals International said Tuesday it divested its Argentina commercial operations to a pharmaceutical company in that country. Financial terms were not disclosed. http://www.ibtimes.com/articles/20080610/valeant-pharma-sells-argentina-commercial-business.htm Tue, 10 Jun 2008 08:25:37 EDT Valeant Pharmaceuticals International said Thursday the Food and Drug Administration stayed its approval decision on a competing version of its topical chemotherapy treatment Efudex. http://www.ibtimes.com/articles/20080515/valeant-says-fda-stays-approval-of-competing-drug.htm Thu, 15 May 2008 08:59:10 EDT